510(k) K023991
K023991 is an FDA 510(k) premarket notification submitted by Precision Biologic for the device "CHROMOCHECK ANTITHROMBIN 25; CHROMOCHECK ANTITHROMBIN 50". The FDA issued a decision of Substantially Equivalent on April 28, 2003. The device falls under product code JBQ (Antithrombin Iii Quantitation), a Class II device regulated under 21 CFR 864.7060. Precision Biologic has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 28, 2003
- Date Received
- December 3, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antithrombin Iii Quantitation
- Device Class
- Class II
- Regulation Number
- 864.7060
- Review Panel
- HE
- Submission Type